Label development and the label comprehension study for over-the-counter drugs

被引：20

作者：

Brass, EP

Weintraub, M

机构：

[1] Univ Calif Los Angeles, Ctr Med, Ctr Clin Pharmacol, Dept Med, Torrance, CA 90502 USA

[2] Lash Grp, Rochester, NY USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 74卷 / 05期

关键词：

D O I：

10.1016/S0009-9236(03)00239-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：406 / 412

页数：7

共 13 条

[1] Drug therapy: Changing the status of drugs from prescription to over-the-counter availability. [J].

Brass, EP .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) :810-816

[2]

Ciociola A A, 2001, Am J Ther, V8, P387, DOI 10.1097/00045391-200111000-00003

[3] Prescription to over-the-counter switch: A regulatory perspective [J].

Juhl, RP .

CLINICAL THERAPEUTICS, 1998, 20 :C111-C117

[4] The "prescription-to-OTC switch" movement -: Its effects on antifungal vaginitis preparations [J].

Lipsky, MS ;

Waters, T .

ARCHIVES OF FAMILY MEDICINE, 1999, 8 (04) :297-300

[5] Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product [J].

Raymond, EG ;

Dalebout, SM ;

Camp, SI .

OBSTETRICS AND GYNECOLOGY, 2002, 100 (02) :342-349

[6]

Sansgiry S S, 1997, J Am Pharm Assoc (Wash), VNS37, P522

[7]

Sansgiry S S, 1997, Health Mark Q, V14, P71

[8]

Sansgiry S S, 2001, Health Mark Q, V19, P61, DOI 10.1300/J026v19n01_05

[9] Usage patterns of over-the-counter phenazopyridine (pyridium) [J].

Shi, CW ;

Asch, SM ;

Fielder, E ;

Gelberg, L ;

Brook, RH ;

Leake, B ;

Shapiro, MF ;

Dowling, P ;

Nichol, M .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (04) :281-287

[10]

U.S. Food and Drug Administration Guidance for Industry, LAB OTC HUM DRUG PRO

← 1 2 →